Evidence map›Paper›PMID 33232360›Full record

ArticlePloS one2020

Context-dependent monoclonal antibodies against protein carbamidomethyl-cysteine.

Naw May Pearl Cartee, Soo Jung Lee, Simon G Keep, Michael M Wang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Naw May Pearl CarteeDepartment of Neurology, University of Michigan, Ann Arbor, MI, United States of America.
Soo Jung LeeDepartment of Neurology, University of Michigan, Ann Arbor, MI, United States of America.
Simon G KeepDepartment of Neurology, University of Michigan, Ann Arbor, MI, United States of America.
Michael M WangDepartment of Neurology, University of Michigan, Ann Arbor, MI, United States of America.ORCID 0000-0002-5670-2496
University of Michigan · US

Funding

NOTCH3 N-terminal fragmentation in cerebral small vessel diseaseR01NS099160 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WANG, MICHAEL M · 2018 to 2022
$1.6M
Notch, LRP, and MMP in Stroke and Vascular DementiaI01BX000375 · VA · VETERANS HEALTH ADMINISTRATION · PI WANG, MICHAEL M · 2009 to 2017
–
Pathological protein generation in cerebral small vessel diseaseI01BX003824 · VA · VETERANS HEALTH ADMINISTRATION · PI Michael M Wang · 2017 to 2026
–
BLRD VA I01 BX000375BLRD VA I01 BX003824BLRD VA I01 BX003855NINDS NIH HHS R01 NS099160
6 · The paper itself

Abstract

Protein sulfhydryl residues participate in key structural and biochemical functions. Alterations in sulfhydryl status, regulated by either reversible redox reactions or by permanent covalent capping, may be challenging to identify. To advance the detection of protein sulfhydryl groups, we describe the production of new Rabbit monoclonal antibodies that react with carbamidomethyl-cysteine (CAM-cys), a product of iodoacetamide (IAM) labeling of protein sulfhydryl residues. These antibodies bind to proteins labeled with IAM (but not N-ethylmaleimide (NEM) or acrylamide) and identify multiple protein bands when applied to Western blots of cell lysates treated with IAM. The monoclonal antibodies label a subset of CAM-cys modified peptide sequences and purified proteins (human von Willebrand Factor (gene:vWF), Jagged 1 (gene:JAG1), Laminin subunit alpha 2 (gene:LAMA2), Thrombospondin-2 (gene:TSP2), and Collagen IV (gene:COL4)) but do not recognize specific proteins such as Bovine serum albumin (gene:BSA) and human Thrombospondin-1 (gene:TSP1), Biglycan (gene:BGN) and Decorin (gene:DCN). Scanning mutants of the peptide sequence used to generate the CAM-cys antibodies elucidated residues required for context dependent reactivity. In addition to recognition of in vitro labeled proteins, the antibodies were used to identify selected sulfhydryl-containing proteins from living cells that were pulse labeled with IAM. Further development of novel CAM-cys monoclonal antibodies in conjunction with other biochemical tools may complement current methods for sulfhydryl detection within specific proteins. Moreover, CAM-cys reactive reagents may be useful when there is a need to label subpopulations of proteins.

Indexed as

AlkylationAmino Acid SequenceAnimalsAntibodies, MonoclonalAntibody SpecificityAntigensBase SequenceBlotting, WesternCattleDisulfidesEnzyme-Linked Immunosorbent AssayEthylmaleimideGreen Fluorescent ProteinsHEK293 CellsHumansIodoacetamideAntibodies, MonoclonalAntigensDisulfidesEthylmaleimideGreen Fluorescent ProteinsIodoacetamidePeptide FragmentsProteinsSulfhydryl Compounds

Identifiers

PMID33232360
PMCPMC7685443
OpenAlexW3107565093

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.